Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Oct 28, 2021
Dr. Nicole Wulf is a clinical pharmacist at FDB and has recently published a study of the current evidence regarding iodine containing compounds and iodine allergy cross-reactivity. Overall they found that there was a lack of evidence that iodine is an allergen and can cause hypersensitivity reactions particularly from contrast media used in imaging.
Nicole explains, "In my job, I'm always looking for ways in which we can improve the allergy alerts for clinicians. This is one thing that I have some questions about, and it made a lot of sense because iodine is part of the thyroid hormone in the body. So to me, it didn't make any sense for us to continue to let people spread the myth that iodine could be an allergen."
"I started pulling the literature and looking at it. It made a lot of sense that this was something that we needed to stop telling people that iodine was an allergen and that we shouldn't be putting it on patient profiles anymore because it was affecting patient care. People might not get the imaging studies they need or not the prescribed amiodarone, even though it's the best choice to treat their rhythm abnormalities."
"Some of the goal was definitely to educate clinicians to stop asking patients, are you allergic to iodine. Or when you're doing an imaging study, stop asking, are you allergic to seafood or shellfish, because they are totally unrelated. The seafood and shellfish reaction is the result of an allergy to a protein, not the iodine."
@FDB_US #ClinicalResearch #IodineAllergy #ImagingTests #MedSafety #PtSafety
